SWTX logo

SpringWorks Therapeutics (SWTX)

Profile

Full Name

SpringWorks Therapeutics, Inc.

Ticker Symbol

SWTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 13, 2019

Indexes

Not included

Website

http://www.springworkstx.com

Employees

368

Key Details

Price

$41.63

Market Cap

$3.12B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$191.59M(+3417.33% YoY)

Annual EPS

-$3.48(+32.43% YoY)

PE Ratio

-

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$41.63
SWTX price is $41.63

Price All-time High

$93.59
SWTX price is currently -55.52% below its historical high of $93.59

Price Most Recent Change

-5.03%
SWTX price was down -5.03% on Apr 1, 2025

Price YTD Change

+13.27%
SWTX price is up +13.27% since January 1st

Price 1-year Change

-11.81%
SWTX price is down -11.81% year-on-year

Price 3-year Change

-26.84%
SWTX price is down -26.84% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$3.12B
SWTX market capitalization is $3.12 billion

Market Cap 3-year Change

+10.96%
SWTX market capitalization is up +10.96% over the past 3 years

Market Cap All-time High

$4.61B
SWTX market capitalization is currently -32.31% below its historical high of $4.61 billion

Market Cap Sector Rank

86.61%
SWTX market capitalization is higher than 86.61% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.18%
SWTX shares outstanding is up +1.18% year-on-year

Shares Outstanding 3-Year Change

+51.67%
SWTX shares outstanding is up +51.67% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.97
SWTX beta is 0.97

200-day SMA

$39.19
SWTX price is currently +6.22% above its 200-day simple moving average

50-day SMA

$47.86
SWTX price is currently -13.01% below its 50-day simple moving average

RSI

33.36
SWTX 14-day relative strength index is 33.36

Volume

1.13
SWTX 30-day relative volume is 1.13

ATR

$2.48
SWTX average true range is $2.48

10-day Historical Volatility

50.04%
SWTX 10-day historical volatility is 50.04%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$191.59M
SWTX annual revenue is $191.59 million

Revenue Analysts Estimate

$349.44M
SWTX annual revenue is currently -45.17% lower than the consensus analysts' forecast

Revenue 1-year Change

+3417.33%
SWTX annual revenue is up +3417.33% year-on-year

Revenue Sector Rank

63.5%
SWTX annual revenue is higher than 63.5% of companies in Healthcare sector

EPS

EPS

-$3.48
SWTX annual earnings per share is -$3.48

EPS Analysts Estimate

-$2.44
SWTX annual earnings per share is currently +42.33% higher than the consensus analysts' forecast

EPS 1-year Change

+32.43%
SWTX annual earnings per share is up +32.43% year-on-year

EPS Sector Rank

26.13%
SWTX annual earnings per share is higher than 26.13% of companies in Healthcare sector

Profit

Gross Profit

$179.04M
SWTX annual gross profit is $179.04 million

Gross Margin

93.45%
SWTX annual gross profit margin is 93.45%

Operating Profit

-$278.13M
SWTX annual operating income is -$278.13 million

Operating Margin

-145.17%
SWTX annual operating profit margin is -145.17%

Net Income

-$258.13M
SWTX annual net profit is -$258.13 million

Net Margin

-134.73%
SWTX annual net profit margin is -134.73%

Expenses

Total Expenses

$469.72M
SWTX annual total expenses is $469.72 million

Operating Expenses

$457.17M
SWTX annual total operating expenses is $457.17 million

Cost Of Goods Sold

$12.55M
SWTX annual cost of goods sold is $12.55 million

Selling, General & Administrative Expenses

$256.65M
SWTX annual SGA is $256.65 million

Depreciation And Amortization

$3.47M
SWTX annual depreciation & amortization is $3.47 million

Interest Expense

-
SWTX annual interest expense value is unknown

Income Tax

-
SWTX annual income tax value is unknown

EBIT & EBITDA

EBIT

-$278.13M
SWTX annual earnings before interest & taxes is -$278.13 million

EBITDA

-$274.66M
SWTX annual EBITDA is -$274.66 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$587.28M
SWTX annual total assets is $587.28 million

Non Current Assets

$206.81M
SWTX annual long term assets is $206.81 million

Current Assets

$380.46M
SWTX annual total current assets is $380.46 million

Cash And Cash Equivalents

$69.75M
SWTX annual cash & cash equivalents is $69.75 million

Accounts Receivable

$46.24M
SWTX annual accounts receivable is $46.24 million

Inventory

$10.21M
SWTX annual inventory is $10.21 million

Liabilities

Total Liabilities

$106.17M
SWTX annual total liabilities is $106.17 million

Long Term Liabilities

$6.18M
SWTX annual total long term liabilities is $6.18 million

Current Liabilities

$99.99M
SWTX annual total current liabilities is $99.99 million

Accounts Payable

$12.25M
SWTX annual accounts payable is $12.25 million

Debt

Total Debt

$7.91M
SWTX annual total debt is $7.91 million

Total Debt 1-year Change

+12.12%
SWTX annual total debt is up +12.12% year-on-year

Long Term Debt

$6.18M
SWTX annual long term debt is $6.18 million

Short Term Debt

$1.73M
SWTX annual short term debt is $1.73 million

Equity & Capital

Shareholders Equity

$481.10M
SWTX annual stockholders equity is $481.10 million

Book Value

$481.10M
SWTX annual book value is $481.10 million

Retained Earnings

-$1.15B
SWTX annual retained earnings is -$1.15 billion

Working Capital

$280.48M
SWTX annual working capital is $280.48 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

-$175.60M
SWTX annual cash flow from operations is -$175.60 million

Cash From Operations 1-year Change

+21.18%
SWTX annual cash flow from operations is up +21.18% year-on-year

Cash From Investing

$64.55M
SWTX annual cash flow from investing activities is $64.55 million

Cash From Investing 1-year Change

+85.72%
SWTX annual cash flow from investing activities is up +85.72% year-on-year

Cash From Financing

$4.76M
SWTX annual cash flow from financing activities is $4.76 million

Cash From Financing 1-year Change

-98.39%
SWTX annual cash flow from financing activities is down -98.39% year-on-year

CAPEX

CAPEX

$20.70M
SWTX annual capital expenditures is $20.70 million

CAPEX 1-year Change

+180.31%
SWTX annual capital expenditures is up +180.31% year-on-year

Free Cash Flow

Free Cash Flow

-$196.30M
SWTX annual free cash flow is -$196.30 million

Free Cash Flow 1-year Change

+14.72%
SWTX annual free cash flow is up +14.72% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

93.45%
SWTX annual gross profit margin is 93.45%

Operating Margin

-145.17%
SWTX annual operating profit margin is -145.17%

Net Margin

-134.73%
SWTX annual net profit margin is -134.73%

ROA & ROE

ROA

-39.32%
SWTX annual return on assets is -39.32%

ROE

-46.62%
SWTX annual return on equity is -46.62%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
SWTX price to earnings ratio value is unknown

PE Ratio Sector Rank

-
SWTX price to earnings ratio is unknown

PB Ratio

PB Ratio

6.48
SWTX price to book ratio is 6.48

PB Ratio Sector Rank

87.01%
SWTX price to book ratio is higher than 87.01% of companies in Healthcare sector

PS Ratio

PS Ratio

16.28
SWTX price to sales ratio is 16.28

PS Ratio Sector Rank

84.73%
SWTX price to sales ratio is higher than 84.73% of companies in Healthcare sector

Enterprise value

Enterprise Value

$3.06B
SWTX enterprise value is $3.06 billion

Enterprise Value Sector Rank

85.22%
SWTX enterprise value is higher than 85.22% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-11.13
SWTX EV/EBITDA is -11.13

EV/EBITDA Sector Rank

10.42%
SWTX EV/EBITDA is higher than 10.42% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

3.81
SWTX annual current ratio is 3.81

Quick Ratio

3.70
SWTX annual quick ratio is 3.70

Leverage

Debt To Equity

0.00
SWTX annual debt to equity ratio is 0.00

Interest Coverage Ratio

-
SWTX annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

2
SWTX piotroski f-score is 2

Altman Z-Score

14.22
SWTX altman z-score is 14.22

Analyst ratings

Recent major analysts updates

Feb 24, 25 HC Wainwright & Co.
Buy
Feb 21, 25 HC Wainwright & Co.
Buy
Feb 12, 25 Wedbush
Outperform
Feb 12, 25 HC Wainwright & Co.
Buy
Feb 12, 25 Evercore ISI Group
Outperform
Jan 8, 25 Guggenheim
Buy
Nov 20, 24 Evercore ISI Group
Outperform
Nov 12, 24 HC Wainwright & Co.
Buy
Sep 4, 24 JP Morgan
Overweight
Aug 28, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

BTSG logo
BrightSpring Health Services (BTSG)
SLNO logo
Soleno Therapeutics (SLNO)
RARE logo
Ultragenyx Pharmaceutical (RARE)
HAE logo
Haemonetics (HAE)
SHC logo
Sotera Health (SHC)
AMED logo
Amedisys (AMED)
RYTM logo
Rhythm Pharmaceuticals (RYTM)
RNA logo
Avidity Biosciences (RNA)
AKRO logo
Akero Therapeutics (AKRO)
  • What is the ticker symbol for SpringWorks Therapeutics?
  • Does SpringWorks Therapeutics pay dividends?
  • What sector is SpringWorks Therapeutics in?
  • What industry is SpringWorks Therapeutics in?
  • What country is SpringWorks Therapeutics based in?
  • When did SpringWorks Therapeutics go public?
  • Is SpringWorks Therapeutics in the S&P 500?
  • Is SpringWorks Therapeutics in the NASDAQ 100?
  • Is SpringWorks Therapeutics in the Dow Jones?
  • When was SpringWorks Therapeutics's last earnings report?
  • When does SpringWorks Therapeutics report earnings?
  • Should I buy SpringWorks Therapeutics stock now?

What is the ticker symbol for SpringWorks Therapeutics?

The ticker symbol for SpringWorks Therapeutics is NASDAQ:SWTX

Does SpringWorks Therapeutics pay dividends?

No, SpringWorks Therapeutics does not pay dividends

What sector is SpringWorks Therapeutics in?

SpringWorks Therapeutics is in the Healthcare sector

What industry is SpringWorks Therapeutics in?

SpringWorks Therapeutics is in the Biotechnology industry

What country is SpringWorks Therapeutics based in?

SpringWorks Therapeutics is headquartered in United States

When did SpringWorks Therapeutics go public?

SpringWorks Therapeutics's initial public offering (IPO) was on September 13, 2019

Is SpringWorks Therapeutics in the S&P 500?

No, SpringWorks Therapeutics is not included in the S&P 500 index

Is SpringWorks Therapeutics in the NASDAQ 100?

No, SpringWorks Therapeutics is not included in the NASDAQ 100 index

Is SpringWorks Therapeutics in the Dow Jones?

No, SpringWorks Therapeutics is not included in the Dow Jones index

When was SpringWorks Therapeutics's last earnings report?

SpringWorks Therapeutics's most recent earnings report was on Feb 20, 2025

When does SpringWorks Therapeutics report earnings?

The next expected earnings date for SpringWorks Therapeutics is May 2, 2025

Should I buy SpringWorks Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page